Form 8-K · Current report
CVS Health 8-K, filed Aug 17, 2026
- Filed
- CIK
- 0000064803
- Accession no.
- 0001193125-26-354096
Summary
CVS Health announced the resignation of Larry M. Robbins from its Board of Directors and the appointment of Teresa Heitsenrether, who currently serves as Executive Vice President and Chief Data & Analytics Officer of JPMorgan Chase & Co., to the Board. Ms. Heitsenrether will join the Board in November 2026, bringing extensive experience in data, analytics, and financial services to the company.
Key points
- Larry M. Robbins resigned from the CVS Health Board, effective August 13, 2026, and the resignation was not related to any disagreement with the company.
- Teresa Heitsenrether was appointed to the Board and is determined by the company to be independent under NYSE Corporate Governance Rules.
- Teresa Heitsenrether's role at CVS Health Board is effective November 18, 2026.
- CEO David Joyner stated that Heitsenrether's background in data, analytics, and AI will be invaluable for CVS Health's path toward becoming a health technology company.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2026, Larry M. Robbins notified the Board of Directors (the “Board”) of CVS Health Corporation (the “Company”) of his resignation from the Board, effective immediately. Mr. Robbins’ resignation was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company. On August 17, 2026, the Board appointed Teresa Heitsenrether to the Board, effective November 18, 2026. Ms. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.